Alzheimer's disease (AD) and Parkinson's disease (PD) are generally considered separate disease entities. However, there is extensive overlap among the clinical and pathologic features, indicating that common mechanisms contribute to neurodegeneration in these disorders. Our preliminary studies from both Emory and Iceland reveal a significantly increased crossed familial risk of AD and PD, suggesting that there are common genetic predispositions in """"""""sporadic"""""""" late-onset cases of both diseases. Capitalizing on the ability to examine extended pedigrees in Iceland in collaboration with deCODE Genetics, our exciting preliminary findings demonstrate novel loci associated with both AD and PD., In the proposed collaborative studies between Emory and deCODE Genetics, we test our central hypothesis that a novel susceptibility gene on chromosome 7p contributes to both AD and PD risk in the Emory ADC subjects, and is more strongly associated with those cases with overlapping cognitive and extrapyramidal features.
In specific aim 1, we test the association of candidate genes at the chromosome 7p locus with AD subjects in a case-control study using subjects in the Emory ADC.
In specific aim 2, we test the association of candidate genes at the chromosome 7p locus with PD subjects in a case-control study using subjects in the Emory Parkinson's Disease Center.
In specific aim 3, we propose to perform detailed genotype-phenotype correlations in the Emory AD and PD subjects to understand more precisely the role of the chromosome 7p locus in the clinical manifestations of AD and PD. Together, these aims will test our central hypothesis and advance our understanding of the complex genetics of AD, PD, and overlap syndromes.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG025688-04
Application #
7618209
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2008-05-01
Budget End
2009-04-30
Support Year
4
Fiscal Year
2008
Total Cost
$270,863
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Johnson, Erik C B; Dammer, Eric B; Duong, Duc M et al. (2018) Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease. Mol Neurodegener 13:52
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
An, Yang; Varma, Vijay R; Varma, Sudhir et al. (2018) Evidence for brain glucose dysregulation in Alzheimer's disease. Alzheimers Dement 14:318-329
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Chandramowlishwaran, Pavithra; Sun, Meng; Casey, Kristin L et al. (2018) Mammalian amyloidogenic proteins promote prion nucleation in yeast. J Biol Chem 293:3436-3450
Bai, Yushi; Chotera, Agata; Taran, Olga et al. (2018) Achieving biopolymer synergy in systems chemistry. Chem Soc Rev 47:5444-5456
Chou, Ching-Chieh; Zhang, Yi; Umoh, Mfon E et al. (2018) TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat Neurosci 21:228-239

Showing the most recent 10 out of 444 publications